Proton beam may spare healthy brain tissue in young tumor patients
NCT ID NCT01049230
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether proton beam radiation can effectively treat germ cell tumors in the brain while causing fewer side effects than standard photon radiation. About 45 participants aged 3 to 25 will receive daily proton radiation for 4 to 8 weeks. Researchers will track side effects and how long the tumor stays under control.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Proton beam radiation
What this could lead to
If successful, this could show that proton radiation is a safer way to treat brain germ cell tumors with fewer long-term side effects than standard radiation.
What could go wrong
This is a small, early-phase study with only 45 participants, so results may not apply to everyone. The treatment still carries risks of radiation side effects, and it is not a cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GERM CELL TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02115, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States